These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Kwiatkowski DJ. Cancer Biol Ther; 2003; 2(5):471-6. PubMed ID: 14614311 [Abstract] [Full Text] [Related]
7. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ. J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [Abstract] [Full Text] [Related]
12. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. Tee AR, Anjum R, Blenis J. J Biol Chem; 2003 Sep 26; 278(39):37288-96. PubMed ID: 12867426 [Abstract] [Full Text] [Related]
14. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ. J Neuropathol Exp Neurol; 2004 Dec 26; 63(12):1236-42. PubMed ID: 15624760 [Abstract] [Full Text] [Related]
15. Insulin like growth factor-1-induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes. Miyazaki M, McCarthy JJ, Esser KA. FEBS J; 2010 May 26; 277(9):2180-91. PubMed ID: 20412061 [Abstract] [Full Text] [Related]
16. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms. Kristof AS, Pacheco-Rodriguez G, Schremmer B, Moss J. J Pharmacol Exp Ther; 2005 Sep 26; 314(3):1134-43. PubMed ID: 15923340 [Abstract] [Full Text] [Related]
17. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N. J Biol Chem; 2005 Sep 16; 280(37):32081-9. PubMed ID: 16027121 [Abstract] [Full Text] [Related]
18. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase. Copps KD, Hançer NJ, Qiu W, White MF. J Biol Chem; 2016 Apr 15; 291(16):8602-17. PubMed ID: 26846849 [Abstract] [Full Text] [Related]
19. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR, Walker CL. Clin Cancer Res; 2008 May 01; 14(9):2543-50. PubMed ID: 18451215 [Abstract] [Full Text] [Related]
20. A complex interplay between Akt, TSC2 and the two mTOR complexes. Huang J, Manning BD. Biochem Soc Trans; 2009 Feb 01; 37(Pt 1):217-22. PubMed ID: 19143635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]